1. CMU Intellectual Repository

Browsing by Author David E. Shapiro

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 2 to 14 of 14 < previous 
Issue DateTitleAuthor(s)
1-May-2009Early postpartum pharmacokinetics of lopinavir initiated intrapartum in Thai womenTim R. Cressey; Russell Van Dyke; Gonzague Jourdain; Thanyawee Puthanakit; Anuvat Roongpisuthipong; Jullapong Achalapong; Prapap Yuthavisuthi; Sinart Prommas; Nantasak Chotivanich; Robert Maupin; Elizabeth Smith; David E. Shapiro; Mark Mirochnick
24-Mar-2020Fosamprenavir with Ritonavir Pharmacokinetics during PregnancyAhizechukwu C. Eke; Jiajia Wang; Khadija Amin; David E. Shapiro; Alice Stek; Elizabeth Smith; Nahida Chakhtoura; Michael Basar; Kathleen George; Katherine M. Knapp; Esaú C. João; Kittipong Rungruengthanakit; Edmund Capparelli; Sandra Burchett; Mark Mirochnick; Brookie M. Best
1-May-2013Pharmacokinetics of an increased atazanavir dose with and without tenofovir during the third trimester of pregnancyRegis Kreitchmann; Brookie M. Best; Jiajia Wang; Alice Stek; Edmund Caparelli; D. Heather Watts; Elizabeth Smith; David E. Shapiro; Steve Rossi; Sandra K. Burchett; Elizabeth Hawkins; Mark Byroads; Tim R. Cressey; Mark Mirochnick
1-Mar-2022Pharmacokinetics of Atazanavir Boosted with Cobicistat in Pregnant and Postpartum Women with HIVJeremiah D. Momper; Jiajia Wang; Alice Stek; David E. Shapiro; Kathleen M. Powis; Mary E. Paul; Martina L. Badell; Renee Browning; Nahida Chakhtoura; Kayla Denson; Kittipong Rungruengthanakit; Kathleen George; Edmund V. Capparelli; Mark Mirochnick; Brookie M. Best
1-Jul-2021Pharmacokinetics of darunavir and cobicistat in pregnant and postpartum women with HIVJeremiah D. Momper; Jiajia Wang; Alice Stek; David E. Shapiro; Gwendolyn B. Scott; Mary E. Paul; Irma L. Febo; Sandra Burchett; Elizabeth Smith; Nahida Chakhtoura; Kayla Denson; Kittipong Rungruengthanakit; Kathleen George; Derek Z. Yang; Edmund V. Capparelli; Mark Mirochnick; Brookie M. Best
1-Jul-2016Pharmacokinetics of Rilpivirine in HIV-Infected Pregnant WomenAnna H. Tran; Brookie M. Best; Alice Stek; Jiajia Wang; Edmund V. Capparelli; Sandra K. Burchett; Regis Kreitchmann; Kittipong Rungruengthanakit; Kathleen George; Tim R. Cressey; Nahida Chakhtoura; Elizabeth Smith; David E. Shapiro; Mark Mirochnick; Shelley Buschur; Chivon Jackson; Mary Paul; Donna McGregor; Ram Yogev; Rohit Kalra; Claudia Florez; Patricia Bryan; Monica Stone; Andrew D. Hull; Mary Caffery; Stephen A. Spector; Joan Wilson; Julieta Giner; Margaret A. Donnelly; Ellen R. Cooper; Debra A. McLaud; Lisa F. Tucker; Jane Hitti; Amanda Robson-Nuss; Ann J. Melvin; Margaret A. Keller; Michael A. Bolaris; Judy Hayes; Françoise Kamer; La Shonda Spencer; James Homans; Torri Metz; Jenna Wallace; Alisa Katai; Mariam Aziz; Maureen McNichols; Julie Schmidt; Diane Wara; Kristinalisa Maka; Deborah Cohan; Audra Deveikis; Jagmohan Batra; Janielle Jackson Alvarez; Michele Carter; Jaime Deville; Carla Janzen; Jenny Gutierrez; Martha Cavallo; Murli Purswani; Katherine M. Knapp; Nina Sublette; Thomas Wride
1-Mar-2021Pharmacokinetics of tenofovir alafenamide with and without cobicistat in pregnant and postpartum women living with HIVKristina M. Brooks; Jeremiah D. Momper; Mauricio Pinilla; Alice M. Stek; Emily Barr; Adriana Weinberg; Jaime G. Deville; Irma L. Febo; Mikhaela Cielo; Kathleen George; Kayla Denson; Kittipong Rungruengthanakit; David E. Shapiro; Elizabeth Smith; Nahida Chakhtoura; James F. Rooney; Richard Haubrich; Rowena Espina; Edmund V. Capparelli; Mark Mirochnick; Brookie M. Best
1-Jul-2022Pharmacokinetics of Tenofovir Alafenamide with Boosted Protease Inhibitors in Pregnant and Postpartum Women Living with HIV: Results from IMPAACT P1026sKristina M. Brooks; Mauricio Pinilla; Alice M. Stek; David E. Shapiro; Emily Barr; Irma L. Febo; Mary E. Paul; Jaime G. Deville; Kathleen George; Kevin Knowles; Kittipong Rungruengthanakit; Renee Browning; Nahida Chakhtoura; Edmund V. Capparelli; Mark Mirochnick; Brookie M. Best
1-Jan-2014Raltegravir pharmacokinetics during pregnancyD. Heather Watts; Alice Stek; Brookie M. Best; Jiajia Wang; Edmund V. Capparelli; Tim R. Cressey; Francesca Aweeka; Patty Lizak; Regis Kreitchmann; Sandra K. Burchett; David E. Shapiro; Elizabeth Hawkins; Elizabeth Smith; Mark Mirochnick
1-May-2020Raltegravir versus efavirenz in antiretroviral-naive pregnant women living with HIV (NICHD P1081): an open-label, randomised, controlled, phase 4 trialEsaú C. João; R. Leavitt Morrison; David E. Shapiro; Nahida Chakhtoura; Maria Isabel S. Gouvèa; Maria de Lourdes B Teixeira; Trevon L. Fuller; Blandina T. Mmbaga; James S. Ngocho; Boniface N. Njau; Avy Violari; Ruth Mathiba; Zaynab Essack; Jose Henrique S. Pilotto; Luis Felipe Moreira; Maria Jose Rolon; Pedro Cahn; Sinart Prommas; Timothy R. Cressey; Kulkanya Chokephaibulkit; Peerawong Werarak; Lauren Laimon; Roslyn Hennessy; Lisa M. Frenkel; Patricia Anthony; Brookie M. Best; George K. Siberry; Mark Mirochnick
1-Sep-2013Reduced indinavir exposure during pregnancyTim R. Cressey; Brookie M. Best; Jullapong Achalapong; Alice Stek; Jiajia Wang; Nantasak Chotivanich; Prapap Yuthavisuthi; Pornnapa Suriyachai; Sinart Prommas; David E. Shapiro; D. Heather Watts; Elizabeth Smith; Edmund Capparelli; Regis Kreitchmann; Mark Mirochnick
31-Jul-2015Resistance detected by pyrosequencing following zidovudine monotherapy for prevention of HIV-1 mother-to-child-transmissionScott C. Olson; Nicole Ngo-Giang-Huong; Ingrid Beck; Wenjie Deng; Paula Britto; David E. Shapiro; Roger E. Bumgarner; James I. Mullins; Russell B. Van Dyke; Gonzague Jourdain; Lisa M. Frenkel
28-Nov-2017Time to first positive HIV-1 DNA PCR may differ with antiretroviral regimen in infants infected with non-B subtype HIV-1Raji Balasubramanian; Mary Glenn Fowler; Kenneth Dominguez; Shahin Lockman; Pat A. Tookey; Nicole Ngo Giang Huong; Steven Nesheim; Michael D. Hughes; Marc Lallemant; Jennifer Tosswill; Nathan Shaffer; Gayle Sherman; Paul Palumbo; David E. Shapiro
Showing results 2 to 14 of 14 < previous